Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
AngioDynamics Inc
SWB:UG2
AngioDynamics Inc
SWB:UG2
Price:
11.1
EUR
-11.9%
Market Closed
Market Cap:
€1.8B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
A
|
AngioDynamics Inc
SWB:UG2
|
US |
|
Baosheng Media Group Holdings Ltd
NASDAQ:BAOS
|
CN |
|
Imperial Petroleum Inc
NASDAQ:IMPP
|
GR |
|
S
|
Shin-Etsu Chemical Co Ltd
XMUN:SEH
|
JP |
|
NGK Corp
F:NGI
|
JP |
|
S
|
Sanlien Technology Corp
TPEX:5493
|
TW |
|
N
|
NGK Corp
XMUN:NGI
|
JP |
|
Athanase Innovation AB
F:H6H
|
SE |
|
I
|
Idex Biometrics ASA
XMUN:I8X
|
NO |
|
Cisarua Mountain Dairy Tbk PT
OTC:CAMDF
|
ID |
|
Pt Astrindo Nusantara Infrastruktur Tbk
F:J9B
|
ID |
Wall St Price Targets
UG2 Price Forecast
Based on 5 analysts
Based on 5 analysts
+56% Upside
from
€11.1
today
AngioDynamics Inc (UG2)’s 12-month stock price forecast through October 2027 has a consensus target of €17.29, implying 56% upside. The forecast is based on price targets from 5 Wall Street analysts.
UG2 Analyst Rating
No ratings yet
No ratings yet
AngioDynamics Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is UG2's stock price target?
Price Target
17.29
EUR
17.29
EUR
According to Wall Street analysts, the average 1-year price target for UG2 is 17.29 EUR with a low forecast of 15.32 EUR and a high forecast of 22.49 EUR.
What is the Revenue forecast for AngioDynamics Inc?
Projected CAGR
7%
7%
Over the last 13 years, the compound annual growth rate for Revenue has been -1%. The projected CAGR for the next 5 years is 7%.
What is the Gross Profit forecast for AngioDynamics Inc?
Projected CAGR
7%
7%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 0%. The projected CAGR for the next 5 years is 7%.
